ARUP's Laboratory Test Directory
| 0060055: Coxsackie B Virus Antibodies |
| Test Mnemonic: COX B | |
|
Methodology: Serum Neutralization Assay
Performed: Mon-Sat Reported: 6-9 days |
| Specimen Required: | |
|
Collect: One 6 mL SST or plain red.
Transport: 3 mL serum at 2-8°C. Also acceptable: CSF. (Min: 1 mL) Submit specimen in an ARUP Standard Transport Tube. Pediatric Collection/Transport: 0.25 mL serum at 2-8°C. Remarks: Separate serum from cells ASAP. Acute and convalescent specimens must be labeled as such; parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of acute specimens. Please mark specimens plainly as "acute" or "convalescent." Unacceptable Conditions: Plasma. Stability: Ambient: 2 days; Refrigerated: 2 weeks; Frozen: 1 year |
|
| Reference Interval: |
|
Coxsackie B1: Less than 1:10 Coxsackie B2: Less than 1:10 Coxsackie B3: Less than 1:10 Coxsackie B4: Less than 1:10 Coxsackie B5: Less than 1:10 Coxsackie B6: Less than 1:10 |
| Interpretive Data: | |
|
Single positive antibody titers of greater than or equal to 1:80 may indicate past or current infection. Seroconversion or an increase in titers between acute and convalescent sera of at least fourfold is considered strong evidence of current or recent infection.
|
| Note: | |
| The clinical significance and criteria for interpretation of results from CSF have not been established. |
| CPT Code(s): | |
| 86658 x6 Coxsackie (B1, B2, B3, B4, B5, and B6) |